FDA Inspection
VitalantVitalant – FDA Inspection, Jan 10, 2025
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on January 10, 2025, issued by the San Francisco District Office, covering biologics.
View Company Profile
ID · 245fd1f8-ee1c-4c17-8cb2-654f0d7df0e2
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1258280
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 29, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 19, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 26, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 29, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1095038 - 2019-06-12
- FDA Inspection 1017575 - 2017-06-29
- FDA Inspection 918958 - 2015-03-19
- FDA Inspection 829294 - 2013-04-26
- FDA Inspection 732726 - 2011-06-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.